Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Thursday, June 5, 2014

REPAIR, REGENERATE & RENEW: Cutting-Edge Stem Cell Research


REPAIR, REGENERATE & RENEW: Cutting-Edge Stem Cell Research at Tisch MS Research Center of New York

Our adult stem cell treatment received FDA approval for a Phase I Clinical Trial that has the potential to repair the damage caused by MS.
This exciting milestone took over ten years to reach and brings indescribable hope to MS patients and their loved ones all over the world. 


Our stem cell therapy is the star of the research program at the Tisch MS Research Center of New York (Tisch MSRCNY), a 501(c)(3), independent, non-profit research center dedicated to finding the cause of and cure for multiple sclerosis (MS). The Center focuses on patient-based research, bringing findings rapidly from the laboratory into clinical application to treat symptoms of MS and to halt or reverse damage caused by the disease. 


In 2007, we started the process of obtaining FDA approval for a Phase I clinical trial. Finally, in August 2013, we received FDA approval to move ahead!
  • The objective of the Phase I trial is to test safety.
  • Data from the Phase I trial will lead to an improved strategy for Phase II
  • Positive outcomes of the trial may indicate the use of this therapy in other neurological diseases like ALS and Parkinson's Disease, cerebral palsy and spinal cord injuries.
Why Stem Cells? 
In pre-clincal, non-human experiments of our stem cell therapy, renewal, repair and regeneration of myelin occurred in the CNS after intrathecal (via spinal fluid, not intravenous) injection.

From our preclinical models, we know that stem cells injected into the spinal fluid can have significant benefit in terms of improved neurological symptoms.

 MS is characterized by brain inflammation, loss of myelin, damage to oligodendrocytes (the cells that make myelin), damage to neurons, and scar formation in the brain. As a result, nerve signals are not properly conducted, causing loss of neurological function. Stem cells are hypothesized to promote repair in MS by migrating to areas of demyelination, blocking damage-forming events, and enabling repair. 
Why Neural Stem Cells?

To learn more, click here


MS Views and News / Stu's Views & MS News 
provides education, information and resources 
for those affected by Multiple Sclerosis

To Keep CURRENT  and up to date with MS News and Information
Sign-up at: 


JOIN our Facebook Page:


Thank you   

Stu's Views & MS News, is a publication of: 

1 comment:

Anonymous said...

This is exciting!

Note that they are using autologous stem cells (from the patient's own body), not the controversial embryonic stem cells harvested from the bodies of aborted babies, so there are no ethical clouds hanging over this research.